These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11858912

  • 21. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.
    Gales AC, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):19-36. PubMed ID: 10744364
    [Abstract] [Full Text] [Related]

  • 22. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria.
    Boucher HW, Wennersten CB, Eliopoulos GM.
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2225-9. PubMed ID: 10898710
    [Abstract] [Full Text] [Related]

  • 23. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ, Beach ML, Jones RN.
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution.
    Werngren J, Olsson-Liljequist B, Gezelius L, Hoffner SE.
    Scand J Infect Dis; 2001 Aug; 33(8):585-8. PubMed ID: 11525351
    [Abstract] [Full Text] [Related]

  • 27. Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United States.
    Gordon KA, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2003 Sep; 47(1):377-83. PubMed ID: 12967754
    [Abstract] [Full Text] [Related]

  • 28. In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.
    Kaya O, Akcam FZ, Temel EN.
    Microb Drug Resist; 2008 Jun; 14(2):151-3. PubMed ID: 18494600
    [Abstract] [Full Text] [Related]

  • 29. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C, Rodríguez-Avial I, Gómez M, Culebras E, López F, Alvarez J, Picazo JJ, Spanish Tigecycline Group.
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
    [Abstract] [Full Text] [Related]

  • 30. Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
    Galles AC, Jones RN, Sader HS.
    J Chemother; 2008 Feb; 20(1):38-42. PubMed ID: 18343741
    [Abstract] [Full Text] [Related]

  • 31. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
    Tuckman M, Petersen PJ, Howe AY, Orlowski M, Mullen S, Chan K, Bradford PA, Jones CH.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci.
    Hoellman DB, Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1085-8. PubMed ID: 10722519
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies.
    Cohn ML, Waites KB.
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2126-8. PubMed ID: 11408235
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.